Cargando…
Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy
BACKGROUND: Our objective was to identify the determinants of high‐density lipoprotein cholesterol efflux capacity (HDL‐CEC) changes in patients with coronary artery disease who participated in a lifestyle modification program aimed at increasing physical activity levels and improving diet quality....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015361/ https://www.ncbi.nlm.nih.gov/pubmed/29858367 http://dx.doi.org/10.1161/JAHA.118.008681 |
_version_ | 1783334395061469184 |
---|---|
author | Boyer, Marjorie Lévesque, Valérie Poirier, Paul Marette, André Mitchell, Patricia L. Mora, Samia Mathieu, Patrick Després, Jean‐Pierre Larose, Éric Arsenault, Benoit J. |
author_facet | Boyer, Marjorie Lévesque, Valérie Poirier, Paul Marette, André Mitchell, Patricia L. Mora, Samia Mathieu, Patrick Després, Jean‐Pierre Larose, Éric Arsenault, Benoit J. |
author_sort | Boyer, Marjorie |
collection | PubMed |
description | BACKGROUND: Our objective was to identify the determinants of high‐density lipoprotein cholesterol efflux capacity (HDL‐CEC) changes in patients with coronary artery disease who participated in a lifestyle modification program aimed at increasing physical activity levels and improving diet quality. METHODS AND RESULTS: A total of 86 men with coronary artery disease aged between 35 and 80 years participated in a 1‐year lifestyle modification program that aimed to achieve a minimum of 150 minutes of aerobic physical activity weekly and improve diet quality. HDL‐CECs were measured before and after the 1‐year intervention using (3)H‐cholesterol–labeled J774 and HepG2 cells. Visceral, subcutaneous, and cardiac adipose tissue levels were assessed before and after the intervention using magnetic resonance imaging. Lipoprotein particle size and concentrations were measured by proton nuclear magnetic resonance spectroscopy and a complete lipoprotein‐lipid profile was obtained. At baseline, the best correlate of HDL‐CECs were apolipoprotein AI (R (2)=0.35, P<0.0001) and high‐density lipoprotein cholesterol (R (2)=0.21, P<0.0001) for J774‐HDL‐CECs and HepG2‐HDL‐CECs, respectively. Baseline and longitudinal changes in HDL‐CECs were associated with several lipoprotein size and concentration indices, although high‐density lipoprotein cholesterol was the best predictor of longitudinal changes in J774‐HDL‐CECs (R (2)=0.18, P=0.002) and apolipoprotein AI was found to be the best predictor of longitudinal changes in HepG2 cholesterol efflux capacities (R (2)=0.21, P=0.002). CONCLUSIONS: Results of this study suggest that increases in high‐density lipoprotein cholesterol and apolipoprotein AI levels typically observed in patients with coronary artery disease undergoing healthy lifestyle modification therapy may be indicative of higher plasma concentrations of functional high‐density lipoprotein particles. |
format | Online Article Text |
id | pubmed-6015361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60153612018-07-05 Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy Boyer, Marjorie Lévesque, Valérie Poirier, Paul Marette, André Mitchell, Patricia L. Mora, Samia Mathieu, Patrick Després, Jean‐Pierre Larose, Éric Arsenault, Benoit J. J Am Heart Assoc Original Research BACKGROUND: Our objective was to identify the determinants of high‐density lipoprotein cholesterol efflux capacity (HDL‐CEC) changes in patients with coronary artery disease who participated in a lifestyle modification program aimed at increasing physical activity levels and improving diet quality. METHODS AND RESULTS: A total of 86 men with coronary artery disease aged between 35 and 80 years participated in a 1‐year lifestyle modification program that aimed to achieve a minimum of 150 minutes of aerobic physical activity weekly and improve diet quality. HDL‐CECs were measured before and after the 1‐year intervention using (3)H‐cholesterol–labeled J774 and HepG2 cells. Visceral, subcutaneous, and cardiac adipose tissue levels were assessed before and after the intervention using magnetic resonance imaging. Lipoprotein particle size and concentrations were measured by proton nuclear magnetic resonance spectroscopy and a complete lipoprotein‐lipid profile was obtained. At baseline, the best correlate of HDL‐CECs were apolipoprotein AI (R (2)=0.35, P<0.0001) and high‐density lipoprotein cholesterol (R (2)=0.21, P<0.0001) for J774‐HDL‐CECs and HepG2‐HDL‐CECs, respectively. Baseline and longitudinal changes in HDL‐CECs were associated with several lipoprotein size and concentration indices, although high‐density lipoprotein cholesterol was the best predictor of longitudinal changes in J774‐HDL‐CECs (R (2)=0.18, P=0.002) and apolipoprotein AI was found to be the best predictor of longitudinal changes in HepG2 cholesterol efflux capacities (R (2)=0.21, P=0.002). CONCLUSIONS: Results of this study suggest that increases in high‐density lipoprotein cholesterol and apolipoprotein AI levels typically observed in patients with coronary artery disease undergoing healthy lifestyle modification therapy may be indicative of higher plasma concentrations of functional high‐density lipoprotein particles. John Wiley and Sons Inc. 2018-06-01 /pmc/articles/PMC6015361/ /pubmed/29858367 http://dx.doi.org/10.1161/JAHA.118.008681 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Boyer, Marjorie Lévesque, Valérie Poirier, Paul Marette, André Mitchell, Patricia L. Mora, Samia Mathieu, Patrick Després, Jean‐Pierre Larose, Éric Arsenault, Benoit J. Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy |
title | Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy |
title_full | Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy |
title_fullStr | Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy |
title_full_unstemmed | Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy |
title_short | Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy |
title_sort | longitudinal changes in cholesterol efflux capacities in patients with coronary artery disease undergoing lifestyle modification therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015361/ https://www.ncbi.nlm.nih.gov/pubmed/29858367 http://dx.doi.org/10.1161/JAHA.118.008681 |
work_keys_str_mv | AT boyermarjorie longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy AT levesquevalerie longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy AT poirierpaul longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy AT maretteandre longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy AT mitchellpatricial longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy AT morasamia longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy AT mathieupatrick longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy AT despresjeanpierre longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy AT laroseeric longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy AT arsenaultbenoitj longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy |